awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36173497-6111A55A-474F-4887-BE6F-2B56DE105A4F
Q36173497-6111A55A-474F-4887-BE6F-2B56DE105A4F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36173497-6111A55A-474F-4887-BE6F-2B56DE105A4F
Detecting overall survival benefit derived from survival postprogression rather than progression-free survival.
P2860
Q36173497-6111A55A-474F-4887-BE6F-2B56DE105A4F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36173497-6111A55A-474F-4887-BE6F-2B56DE105A4F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ac047993d07815c03b6cd43a5c7cbcda98df2729
P2860
Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study.